The Merck Index 10th Ed., 1983 pp. 491-492. |
The Merck Index 14th Ed., 1996 p. 1052 [Metyrosine]. |
R. Landgraf et al.; “Prolactin: A Diabetogenic Hormone”, Diabetologia 13, 1977, pp. 99-104, 1976. |
The Pharmacological Basis of Therapeutics, Seventh Edition (Chapters 18, p. 383), 1985. |
Atkinson et al., “Effects of Long-Term Theraphy with Nultrexone on Body Weight in Obesity” Clin. Pharmacol. Ther. Oct. 1985: pp. 419-422. |
J. R. Givens et al.; “Reduction of Hyperinsulinemia” J. Clin. Endocr. & Metab. 64/2, 1987, pp. 377-382. |
G. R. Van Loon et al.; Endocrinology; vol. 109, p. 46, 1981. |
R. Vink et al.; “K-Opioid Antagonist Improves Cellular Bioenergetics and Recovery After Traumatic Brain Injury” Am. J. Physiol. 261, 1991. |
Sohel et al. “Influence of Adrenergic Blockers and Antilipemic Agents on Pharmacodynamic Actions of Morphine in Carbon Tetrachloride-Treated Rats.” Toxicol Appl Pharmacol 27 (3): 477-483, Mar., 1974. |
Stern et al. “Lack of Awareness and Treatment of Hyperlipidemia in Type II Diabetes in a Community Survey.” JAMA 262 (3) : 360-4, Jul., 1989. |
Herz A. “Bidirectional Effects of Opioids in Motivational Processes and the Involvement of D1 Dopamine Receptors.” NIDA Res Monogr 1988;90:17-26. |
Herz A.; “Opioid Reward Mechanisms: A Key Role in Drug Abuse?” Can J. Physiol Pharmacol 76, 3:252-8, 1998. |
Pan Z.Z.; “mu-Opposing Actions of the Kappa-Opioid Receptor” Thrends Pharmacol Sci; 19, 3: 94-8, 1998. |
Porotoghese, et al.; “Binaltorphimine and Nor-Binal Torphimine, Potent and Selective k-Opioid Receptor Antagonists” Life Sciences 40:1287-92, 1987. |
Jones et al.; Journal of Medicinal Chemistry 41, 25: 4911-4, 1998. |
Merz et al.; Advances in biochemical psychopharmacology, vol. 8 : 91-107, 1974. |
Porotoghese et al.; “TENA, A Selective Kappa Opioid Receptor Antagonist” LIfe Sciences 36:801-5, 1984. |
Lewis J.W.; “Buprenorphine” Drug and Alcohol Dependence; 14:363-372, 1985. |
McQuay J.J. et al.; “Clinical Effects of Buprenorphine During and After Operation” Br J. Anaesth; 52:1013-19, 1980. |
Ruppin H.; “Loperamide--A Potent Antidiarrhoeal Drug with Actions Along the Alimentary Tract” Aliment Pharmacol Ther 1987, 1(3): 179-190. |
Caldara R. et al.; “Effect of Loperamide, a Peripheral Opiate Agonist, on Circulating Glucose, Free Fatty Acids, Insulin, C-Peptide and Pituitary Hormones in Healthy Man” Eur J. Clin Pharmacol; 21, 3:185-8, 1981. |
Buzi F. et al.; “Loperamide Test: a Simple and Highly Specific Screening Test for Hypercortisolism in Children and Adolescents” Acta Paediatr; 86, 11: 1177-80, 1997. |
Foss et al.; “Restoration of Glucose Homeostasis in Insulin-Dependent Diabetic Subjects”; Diabetes, 31:46-52, 1982. |
Pfeifer et al.; “Insulin Secretion in Diabetes Mellitus”; The American Journal of Medicine, 70:579-588, 1981. |
Felber et al.; “Effect of a 3-Day Fast on Glucose Storage and Oxidation in Obese Hyperinsulinemic Diabetics; Metabolism, 30,2; 184-189 and Diabetologia, 20:39-44, 1981. |
Edelman, S.V.; “Prescribing Oral Antidiabetic Agents: General Considerations”; Clinical Diabetes 16,1:37-40, 1998. |